Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance

Published:2015-02-18 Issue:5 Volume:131 Page:259-267
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Lee J.-H.¹,Jeong S.-K.²,Kim B. C.³,Park K. W.⁴,Dash A.⁵

Affiliation:

1. Department of Neurology; Asan Medical Center; University of Ulsan College of Medicine; Seoul Korea

2. Department of Neurology; Chonbuk National University Medical School; Jeonju Korea

3. Department of Neurology; Chonnam National University Medical School; Gwangju Korea

4. Department of Neurology; Dong-A University College of Medicine; Busan Metropolitan Dementia Center; Busan Korea

5. Eisai Co. Ltd; Mumbai India

Funder

Eisai (Singapore) Pte Ltd

Publisher

Wiley

Subject

Clinical Neurology,Neurology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ane.12386/fullpdf

Reference24 articles.

1. Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: a subgroup analysis in patients already taking or not taking concomitant memantine;Doody;Dement Geriatr Cogn Disord,2012

2. Alzheimer's Disease International World Alzheimer Report 2009: the global prevalence of dementia http://www.alz.co.uk/research/world-report-2009

3. High-dose donepezil (23 mg/day) for the treatment of moderate and severe Alzheimer's disease: drug profile and clinical guidelines;Cummings;CNS Neurosci Ther,2013

4. Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer's disease: evaluating the impact of baseline severity;Ferris;Alzheimer's Res Ther,2013

5. Language impairment in Alzheimer's disease and benefits of acetylcholinesterase inhibitors;Ferris;Clin Interv Aging,2013

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pongamol Alleviates Neuroinflammation and Promotes Autophagy in Alzheimer’s Disease by Regulating the Akt/mTOR Signaling Pathway;Journal of Agricultural and Food Chemistry;2024-06-06

2. Rational Design of Dual-Functionalized Gd@C₈₂ Nanoparticles to Relieve Neuronal Cytotoxicity in Alzheimer’s Disease via Inhibition of Aβ Aggregation;ACS Nano;2024-06-05

3. Rational drug repurposing for alzheimer’s treatment using in-silico ligand and structure-based approaches;Brazilian Journal of Pharmaceutical Sciences;2024

4. Natural plant materials as a source of neuroprotective peptides;Current Medicinal Chemistry;2023-07-03

5. Phytopharmaceuticals and Herbal Approaches to Target Neurodegenerative Disorders;Drug Research;2023-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3